Kirti Shah, MD
Nephrology · Lawrenceville, GANPI 1700881612
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,657 of the $1,913 with a category attached, or 86.6%. It is spread thinly across 20 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for nephrology clinicians in GA, where the typical reported total is $1,554.
Across 83 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$274
- AstraZeneca$225
- OPKO Pharmaceuticals, LLC$210
- Ironshore Pharmaceuticals Inc.$207
- Stryker$141
- Novartis$121
- plus $735 from 14 others
Across 246 payments — averaging $1071.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Akebia Therapeutics Inc$264K
What the payments were for
- Food & beverage$1,65787%
- Education$25613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 14 | $274 |
| AstraZeneca | 16 | $225 |
| OPKO Pharmaceuticals, LLC | 11 | $210 |
| Ironshore Pharmaceuticals Inc. | 2 | $207 |
| Stryker | 1 | $141 |
| Novartis | 5 | $121 |
| Aurinia Pharma U.S., Inc. | 8 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| GSK | 6 | $108 |
| Akebia Therapeutics Inc | 3 | $74 |
| Vifor Pharma, Inc. | 3 | $73 |
| Cormedix Inc. | 2 | $49 |
| Daiichi Sankyo Inc. | 3 | $44 |
| Calliditas Therapeutics US Inc. | 2 | $39 |
| Bayer | 1 | $26 |
| Ardelyx, Inc. | 1 | $23 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Novo Nordisk | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
| Rockwell Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,913 in reported general payments places this provider in the 50th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 62 | $57,821 |
| JanuviaSitagliptin Phosphate | 33 | $29,870 |
| LokelmaSodium Zirconium Cyclosilicate | 12 | $8,329 |
| Calcium Acetate | 63 | $5,620 |
| SpsSodium Polystyrene Sulfon/Sorb | 11 | $4,420 |
| Cinacalcet Hcl | 16 | $3,690 |
| Sevelamer Carbonate | 32 | $3,434 |
| Calcitriol | 73 | $1,508 |
| Torsemide | 97 | $1,350 |
| Sodium Polystyrene Sulfonate | 11 | $1,310 |
| Nifedipine ErNifedipine | 45 | $1,074 |
| Hydralazine Hcl | 71 | $1,018 |
| Metolazone | 24 | $975 |
| Midodrine Hcl | 11 | $834 |
| Atorvastatin Calcium | 93 | $768 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $225 | $66,15074 claims |
| StrykerSps | $141 | $4,42011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 388 nephrology providers in Georgia.
Other nephrology in Lawrenceville
- James TumlinLawrenceville$434K
- William PaxtonLawrenceville$73K
- Sharad VirmaniLawrenceville$55K
- Lorin SanchezLawrenceville$23K
- Aakash AminLawrenceville$22K
- Kathryn ElmoreLawrenceville$12K
- Shaun ConlonLawrenceville$11K
- Nnamdi NwaohiriLawrenceville$11K
- Jusong ChoiLawrenceville$8K
- Sagar PanseMacon$542K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.